3-(2,2,2-trimethylhydrazine)propionate and Angor Pectoris

3-(2,2,2-trimethylhydrazine)propionate has been researched along with Angor Pectoris in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Maisch, B; Rupp, H; Zarain-Herzberg, A	1
Kalvinsh, I; Kloner, RA; Sesti, C; Simkhovich, BZ	1
Baiandin, NL; Gordeev, IG; Il'ina, EE; Kuznechevskiĭ, FV; Liusov, VA	1
Dudko, VA; Koshel'skaia, OA; Sokolov, AA	1

Reviews

1 review(s) available for 3-(2,2,2-trimethylhydrazine)propionate and Angor Pectoris

Article	Year
The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz, 2002, Volume: 27, Issue:7 Topics: Acetanilides; Angina Pectoris; Animals; Calcium; Cardiovascular Agents; Clinical Trials as Topic; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Gene Expression; Glucose; Heart Failure; Humans; Hypoglycemic Agents; Methylhydrazines; Myocytes, Cardiac; Oxidation-Reduction; Piperazines; Ranolazine; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Trimetazidine; Up-Regulation; Vasodilator Agents	2002

Article

Year

The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.

Herz, 2002, Volume: 27, Issue:7

Topics: Acetanilides; Angina Pectoris; Animals; Calcium; Cardiovascular Agents; Clinical Trials as Topic; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Gene Expression; Glucose; Heart Failure; Humans; Hypoglycemic Agents; Methylhydrazines; Myocytes, Cardiac; Oxidation-Reduction; Piperazines; Ranolazine; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Trimetazidine; Up-Regulation; Vasodilator Agents

2002

Trials

1 trial(s) available for 3-(2,2,2-trimethylhydrazine)propionate and Angor Pectoris

Article	Year
[The use of mildronat with stenocardia patients]. Vrachebnoe delo, 1989, Issue:10 Topics: Adult; Angina Pectoris; Cardiovascular Agents; Exercise Test; Humans; Male; Methylhydrazines; Middle Aged; Physical Endurance; Randomized Controlled Trials as Topic; Spirometry	1989

Other Studies

2 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Angor Pectoris

Article	Year
Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics. Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:3 Topics: Angina Pectoris; Animals; Blood Pressure; Body Weight; Cardiovascular Agents; Fatty Acids; Female; Heart Rate; Methylhydrazines; Myocardial Infarction; Oxidation-Reduction; Rats; Rats, Sprague-Dawley	2006
[Derangements of contractility of left ventricular myocardium in patients subjected to coronary bypass surgery. Methods of their correction]. Kardiologiia, 2007, Volume: 47, Issue:2 Topics: Adult; Aged; Angina Pectoris; Cardiotonic Agents; Coronary Artery Bypass; Female; Humans; Male; Methylhydrazines; Middle Aged; Myocardial Contraction; Postoperative Complications; Trimetazidine; Ventricular Dysfunction, Left	2007

Article

Year

Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics.

Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:3

Topics: Angina Pectoris; Animals; Blood Pressure; Body Weight; Cardiovascular Agents; Fatty Acids; Female; Heart Rate; Methylhydrazines; Myocardial Infarction; Oxidation-Reduction; Rats; Rats, Sprague-Dawley

2006

[Derangements of contractility of left ventricular myocardium in patients subjected to coronary bypass surgery. Methods of their correction].

Kardiologiia, 2007, Volume: 47, Issue:2

Topics: Adult; Aged; Angina Pectoris; Cardiotonic Agents; Coronary Artery Bypass; Female; Humans; Male; Methylhydrazines; Middle Aged; Myocardial Contraction; Postoperative Complications; Trimetazidine; Ventricular Dysfunction, Left

2007